Literature DB >> 74547

Decrease in serum-prolactin after propranolol in schizophrenia.

T Hanssen, T Heyden, I Sundberg, L Wetterberg, P Eneroth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 74547     DOI： 10.1016/s0140-6736(78)90046-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin.

Authors:  O Lederballe Pedersen; E Mikkelsen; J Lanng Nielsen; N J Christensen
Journal:  Eur J Clin Pharmacol       Date:  1979-04-17       Impact factor: 2.953

Review 2.  Neuroendocrine markers of CNS drug effects.

Authors:  E C Johnstone; I N Ferrier
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

Review 3.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

4.  Plasma prolactin levels before and during propranolol treatment in chronic schizophrenia.

Authors:  J D Wilson; D J King; B Sheridan
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

5.  The effect of propranolol treatment in shizophrenia on CSF amine metabolites and prolactin.

Authors:  R H Belmaker; R P Ebstein; H Dasberg; A Levy; G Sedvall; H M Van Praag
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

6.  Action of d-propranolol in manic psychoses.

Authors:  H J Möller; D von Zerssen; H M Emrich; W Kissling; C Cording; H J Schietsch; E Riedel
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979-12

7.  The effect of propranolol on CSF amine metabolites in psychiatric patients.

Authors:  D J King; S J Cooper; J Liddle
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.